SP1 and pancreatic neoplasm: Metformin is an antidiabetic drug that protects patients against pancreatic cancer and metformin downregulates Sp1, Sp3, Sp4 and pro-oncogenic Sp-regulated genes in pancreatic cancer cells and tumors [33].